[Cancer and cardiovascular disease]

Clin Investig Arterioscler. 2015 Sep-Oct;27(5):221-5. doi: 10.1016/j.arteri.2015.02.002. Epub 2015 Mar 12.
[Article in Spanish]

Abstract

Survivors of cancer have a shorter survival in the long term partly due to the increase in cardiovascular diseases (CVD). Some chemotherapy drugs, thoracic and cranial radiotherapy and above all the transplantation of hematopoietic cells are associated with an increase in the incidence of cardiovascular events compared with general population. Some of these treatments favor the development of a metabolic syndrome that could be the intermediary between these treatments and the development of CVD. It is recommended for cancer survivors to promote healthy lifestyles and the strict control of cardiovascular risk factors.

Keywords: Cancer; Cardiovascular disease; Enfermedad cardiovascular; Transplantation of hematopoietic cells; Transplante de células hematopoyéticas.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Life Style
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / etiology*
  • Neoplasms / therapy*
  • Risk Factors
  • Survival Rate
  • Survivors

Substances

  • Antineoplastic Agents